Business
ProtoKinetix Releases First in a Series of Scientific Update Videos
ProtoKinetix Releases First in a Series of Scientific Update Videos.
About this update from Protokinetix, Inc.
[{"type":"text","content":"\n \n ProtoKinetix, Incorporated (www.protokinetix.com) \n (the \"Company\" or \"ProtoKinetix\") (OTCQB:PKTX) \n announces the launch of the first in a series of informational videos by \n the Principal Investigators in each field currently being tested.\n \n \n The first video is an update on the clinical trial of AAGP™ PKX-001 \n treated islet cells used in conjunction with the Edmonton Protocol for \n the treatment of Type 1 diabetes led by Dr. James Shapiro, MD, PhD, \n FRCSC, MSM FCAHS, AHS Director of Clinical Islet and Living Donor Liver \n Transplant Programs, Canada Research Chair in Transplant Surgery and \n Regenerative Medicine, Professor of Surgery, Medicine and Surgical \n Oncology, University of Alberta.\n \n \n Dr. \n James Shapiro on AAGP™\n \n \n Click \n here for more on Dr. Shapiro and the Edmonton Protocol\n \n \n About ProtoKinetix, Incorporated\n \n \n ProtoKinetix is a molecular biotechnology company that has developed and \n patented a family of hyper stable, potent glycopeptides (AAGP®) that \n enhance both engraftment and protection of transplanted cells used in \n regenerative medicine. Due to the results achieved over the last four \n years of testing, the University of Alberta has begun Phase 1 human \n clinical trials. Additional studies will be expanded to include whole \n organ transplantation and all therapies that are being developed \n globally to date; cancer, diabetes, retinal degeneration, and cardiac \n muscle repair.\n \n \n Cautionary Note Regarding Forward-Looking Statements\n \n \n The information discussed in this press release includes “forward \n looking statements” within the meaning of Section 27A of the Securities \n Act of 1933 (the “Securities Act”) and Section 21E of the Securities \n Exchange Act of 1934 (the “Exchange Act”). All statements, other \n than statements of historical facts, included herein concerning, among \n other things, planned capital expenditures, future cash flows and \n borrowings, pursuit of potential acquisition opportunities, our \n financial position, business strategy and other plans and objectives for \n future operations, are forward looking statements. These forward looking \n statements are identified by their use of terms and phrases such as \n “may,” “expect,” “e...